When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal

Isaac Corro Ramos (), Susan O’Meara, Mubarak Patel, Lisa Stirk, Jiongyu Chen, Xiaoyu Tian and Nigel Armstrong
Additional contact information
Isaac Corro Ramos: Erasmus University Rotterdam
Susan O’Meara: University of York
Mubarak Patel: Kleijnen Systematic Reviews Ltd
Lisa Stirk: Kleijnen Systematic Reviews Ltd
Jiongyu Chen: University of York
Xiaoyu Tian: Kleijnen Systematic Reviews Ltd
Nigel Armstrong: Kleijnen Systematic Reviews Ltd

PharmacoEconomics, 2025, vol. 43, issue 8, No 1, 845-848

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-025-01505-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:43:y:2025:i:8:d:10.1007_s40273-025-01505-z

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-025-01505-z

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().